Roche Holding Ltd ADR (RHHBY)

41.55
+0.19(+0.46%)
After Hours
41.62
+0.07(+0.17%)
- Delayed Data
  • Volume:
    686,286
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    41.53 - 41.91

RHHBY Overview

Prev. Close
41.36
Day's Range
41.53-41.91
Revenue
65.32B
Open
41.69
52 wk Range
37.88-53.86
EPS
17.85
Volume
686,286
Market Cap
275.81B
Dividend (Yield)
0.7765
(1.87%)
Average Volume (3m)
2,044,845
P/E Ratio
17.67
Beta
0.297
1-Year Change
-15.33%
Shares Outstanding
801,094,291
Next Earnings Date
17 Oct 2022
What is your sentiment on Roche Holding ADR?
or
Market is currently closed. Voting is open during market hours.

Roche Holding Ltd ADR Analysis

Roche Holding Ltd ADR Company Profile

Roche Holding Ltd ADR Company Profile

Employees
100920

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellSellSellSell
Technical IndicatorsStrong SellStrong SellBuyStrong SellStrong Sell
SummaryStrong SellStrong SellNeutralStrong SellStrong Sell